| # | Drug | Count |
|---|---|---|
| 0 | NEVIRAPINE | 3 |
| 1 | ACETAMINOPHEN | 2 |
| 2 | ACETAMINOPHEN 500MG | 2 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 4 | EFAVIRENZ | 2 |
| 5 | ESCITALOPRAM | 2 |
| 6 | ESCITALOPRAM OXALATE | 2 |
| 7 | LAMIVUDINE | 2 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 2 |
| 9 | LAMIVUDINE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELAPEGADEMASE-LVLR | 1 | 0.0033 |
| 1 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| 2 | NEVIRAPINE | 3 | 0.0003 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 2 | 0.0003 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 5 | METHYLDOPA | 1 | 0.0002 |
| 6 | EFAVIRENZ | 2 | 0.0002 |
| 7 | PHYTONADIONE | 1 | 0.0001 |
| 8 | DOLUTEGRAVIR SODIUM | 1 | 0.0001 |
| 9 | CAPTOPRIL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 1 | Vitamin K [EPC] | 1 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 4 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 5 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 6 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |